Cargando…
Protection of transplants against antibody-mediated injuries: from xenotransplantation to allogeneic transplantation, mechanisms and therapeutic insights
Long-term allograft survival in allotransplantation, especially in kidney and heart transplantation, is mainly limited by the occurrence of antibody-mediated rejection due to anti-Human Leukocyte Antigen antibodies. These types of rejection are difficult to handle and chronic endothelial damages are...
Autores principales: | Kervella, Delphine, Le Bas-Bernardet, Stéphanie, Bruneau, Sarah, Blancho, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389360/ https://www.ncbi.nlm.nih.gov/pubmed/35990687 http://dx.doi.org/10.3389/fimmu.2022.932242 |
Ejemplares similares
-
MHC Class I Masking to Prevent AMR in a Porcine Kidney Transplantation Model in Alloimmunized Recipients
por: Kervella, Delphine, et al.
Publicado: (2023) -
Sterile Pancreas Inflammation during Preservation and after Transplantation
por: Kervella, Delphine, et al.
Publicado: (2023) -
Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation
por: Nayak, Deepak Kumar, et al.
Publicado: (2016) -
Evaluation of FR104, a Treg sparing antagonist anti-CD28 monovalent Fab’ antibody in kidney transplantation in non-human primates
por: Poirier, Nicolas, et al.
Publicado: (2012) -
Time-Limited Therapy with Belatacept in Kidney Transplant Recipients
por: Letellier, Thibault, et al.
Publicado: (2022)